Proximal Ventures raises debut fund to back startups bringing AI to drug development

🇺🇸 TechCrunch (US) —
Proximal Ventures raises debut fund to back startups bringing AI to drug development

AI Summary

Sahir Raoof has raised a $27.5 million debut fund through Proximal Ventures to invest in startups applying AI to drug development. The fund targets the intersection of artificial intelligence and pharmaceutical research.

Former SignalFire investor Sahir Raoof raises $27.5M for new fund targeting AI in pharma

Markets Deals Health AI & Tech venture capital AI drug development pharma fundraising startups

Read original source →